SEER Seer, Inc.
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1726445 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-14.0%
TTM net income YoY20.0%
TTM EPS YoY—
Revenue 3-yr CAGR-5.8%
Net income 3-yr CAGR—
Margins
Gross margin46.5%
Operating margin-469.9%
Net margin-450.9%
FCF margin-329.3%
EBITDA margin-438.2%
Returns
ROE-26.2%
ROA-23.1%
ROIC (approx.)-25.5%
Asset turnover0.05x
Leverage & solvency
Liabilities / assets12.0%
Debt / equity0.00x
Current ratio16.89x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.71x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue7.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.98M | $3.10M | $2.79M | $4.20M | $4.12M | $4.05M | $4.21M | $4.00M |
| Cost of revenue | $2.10M | $1.60M | $1.81M | $2.02M | $2.01M | $1.94M | $2.14M | $1.98M |
| Gross profit | $1.88M | $1.51M | $982,000 | $2.18M | $2.11M | $2.11M | $2.06M | $2.02M |
| R&D expense | $6.44M | $8.21M | $8.81M | $9.74M | $10.80M | $11.98M | $11.35M | $12.62M |
| SG&A expense | $10.11M | $10.14M | $9.43M | $9.83M | $10.66M | $10.66M | $11.44M | $12.89M |
| Operating income | -$14.67M | -$16.84M | -$17.26M | -$17.39M | -$19.35M | -$20.53M | -$20.73M | -$23.49M |
| Pretax income | -$13.73M | -$16.89M | -$16.83M | -$15.97M | -$18.21M | -$19.38M | -$19.85M | -$21.64M |
| Income tax | $5,000 | $9,000 | $10,000 | $28,000 | $24,000 | $48,000 | $101,000 | $98,000 |
| Net income | -$13.74M | -$16.90M | -$16.84M | -$15.99M | -$18.23M | -$19.42M | -$19.95M | -$21.74M |
| EBITDA | -$13.65M | -$15.72M | -$16.10M | -$16.22M | -$18.14M | -$19.20M | -$19.31M | -$22.02M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Dividends declared per share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance sheet | ||||||||
| Cash & equivalents | $29.32M | $26.07M | $47.32M | $47.28M | $44.97M | $37.93M | $52.45M | $41.28M |
| Short-term investments | $126.58M | $126.78M | $119.35M | $138.61M | $154.26M | $171.90M | $187.28M | $195.66M |
| Inventory | $6.40M | $7.66M | $8.08M | $7.79M | $8.13M | $7.51M | $7.07M | $7.44M |
| Current assets | $167.90M | $166.10M | $181.59M | $201.53M | $214.36M | $225.64M | $255.27M | $253.32M |
| PP&E, net | $11.03M | $12.18M | $13.48M | $14.75M | $15.47M | $16.50M | $17.04M | $18.57M |
| Total assets | $241.80M | $256.64M | $272.13M | $296.08M | $308.61M | $322.49M | $347.26M | $366.60M |
| Current liabilities | $9.94M | $11.27M | $10.24M | $15.69M | $15.04M | $11.79M | $13.20M | $15.33M |
| Total liabilities | $28.91M | $30.96M | $30.65M | $36.78M | $36.79M | $34.20M | $36.26M | $39.03M |
| Shareholders' equity | $212.89M | $225.68M | $241.48M | $259.31M | $271.81M | $288.29M | $311.01M | $327.57M |
| Cash flow statement | ||||||||
| Operating cash flow | -$9.53M | -$9.57M | -$15.44M | -$10.81M | -$7.57M | -$14.66M | -$11.42M | -$11.46M |
| Capital expenditure | $436,000 | $9,000 | $270,000 | $292,000 | $283,000 | $568,000 | $654,000 | -$536,000 |
| Free cash flow | -$9.97M | -$9.58M | -$15.71M | -$11.10M | -$7.85M | -$15.23M | -$12.07M | -$10.92M |
| Investing cash flow | $12.64M | -$11.47M | $18.08M | $12.98M | $16.60M | $7.36M | $24.61M | $15.85M |
| Financing cash flow | $128,000 | -$205,000 | -$2.61M | $143,000 | -$1.99M | -$7.22M | -$1.50M | -$1.26M |
| Depreciation & amortization | $1.02M | $1.12M | $1.16M | $1.16M | $1.21M | $1.33M | $1.42M | $1.47M |
| Stock-based compensation | $1.22M | $1.56M | $2.13M | $3.29M | $3.59M | $3.87M | $4.66M | $6.44M |
| Share buybacks | — | — | — | — | — | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.